View Older Stories
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A SERA PROGNOSTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Enliven Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Praxis Precision Medicin Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tourmaline Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Apogee Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A BICYCLE THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Structure Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Alto Neuroscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
-
Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G BRIGHT MINDS BIOSCIENCES Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Avalo Therapuetics (AVTX) Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
-
Form SC 13G GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Ensysce Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D Septerna, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Bright Minds Biosciences (DRUG) Closes US$35 Million Non-Brokered Private Placement
-
Form SC 13G Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement
-
Eledon Pharmaceuticals (ELDN) Prices $85M Offering at $3.65/sh
-
Monopar Therapeutics (MNPR) Prices $19.2M Share Offering at $16.25/sh
-
AbbVie (ABBV) Acquires Aliada Therapeutics
-
Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Janux Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G BioAge Labs, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D Bicara Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Cidara Therapeutics (CDTX) Announces Scientific Advisory Board with Infectious Disease Experts
-
Form SC 13D/A Janux Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.